发明名称 6,5-HETEROBICYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHOD OF TREATING DISEASES
摘要 <p>This invention relates to compounds of formula (I), wherein the dashed lines represent optional double bonds; A is nitrogen or CR<7>; B is -NR<1>R<2>, -CR<1>R<2>R<10>-C(=CR<2>R<11>)R<1>, -NHCR<1>R<2>R<10>, -OCR<1>R<2>R<10>, -SCR<1>R<2>R<10>, -CR<2>R<10>NHR<1>, -CR<2>R<10>OR<1>, -CR<2>R<10>SR<1> or -COR<2>; J and K are each independently nitrogen or carbon and both J and K are not nitrogens; D and E are each selected, independently, from nitrogen, CR<4>, C=O, C=S, sulfur, oxygen, CR<4>R<6> and NR<8>; G is nitrogen or carbon; and their use for the prevention or inhibition of a disorder that can be treated by antagonizing CRF.</p>
申请公布号 CZ9900681(A3) 申请公布日期 1999.11.17
申请号 CZ19990000681 申请日期 1997.07.25
申请人 PFIZER INC. 发明人 CHEN YUHPYNG LIANG
分类号 A61K31/00;A61K31/435;A61K31/4353;A61K31/437;A61K31/505;A61K31/519;A61K31/529;A61P1/00;A61P1/04;A61P1/12;A61P1/14;A61P3/00;A61P3/04;A61P3/08;A61P5/24;A61P5/42;A61P7/12;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/00;A61P13/02;A61P15/00;A61P15/06;A61P15/08;A61P17/02;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P21/00;A61P21/02;A61P25/00;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P25/36;A61P29/00;A61P31/00;A61P31/18;A61P35/00;A61P37/00;A61P37/04;A61P37/08;A61P43/00;C07D471/04;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K31/00
代理机构 代理人
主权项
地址